Comment on Dornoff et al.: Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck.

Suppr

超能文献

作者信息

Müller Klaus, Klautke Gunther

机构信息

Department for Radiation Oncology, Hospital of Chemnitz, Bürgerstraße 2, 09113, Chemnitz, Germany.

出版信息

Strahlenther Onkol. 2015 Dec;191(12):985. doi: 10.1007/s00066-015-0908-1. Epub 2015 Oct 16.

DOI:10.1007/s00066-015-0908-1

PMID:26475340

Abstract

摘要

相似文献

Comment on Dornoff et al.: Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck.

Strahlenther Onkol. 2015 Dec;191(12):985. doi: 10.1007/s00066-015-0908-1. Epub 2015 Oct 16.

Reply to: Comment on Dornoff et al.: Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck.

Strahlenther Onkol. 2015 Dec;191(12):986. doi: 10.1007/s00066-015-0911-6.

Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck.使用西妥昔单抗或基于顺铂的化疗对头颈部复发性鳞状细胞癌进行再照射。

Strahlenther Onkol. 2015 Aug;191(8):656-64. doi: 10.1007/s00066-015-0854-y. Epub 2015 May 25.

TPF induction chemotherapy and concomitant irradiation with cisplatin and cetuximab in unresectable squamous cell carcinoma of the head and neck.TPF诱导化疗联合顺铂和西妥昔单抗同步放疗用于不可切除的头颈部鳞状细胞癌

Head Neck. 2014 Nov;36(11):1555-61. doi: 10.1002/hed.23506. Epub 2013 Dec 18.

Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck : Final 5‑year results of a phase II study.超分割加速放疗联合西妥昔单抗和顺铂化疗治疗局部晚期不可切除头颈部鳞状细胞癌：一项II期研究的5年最终结果

Strahlenther Onkol. 2017 Sep;193(9):733-741. doi: 10.1007/s00066-017-1145-6. Epub 2017 May 12.

Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer: Results of a randomized phase II study.多西他赛、顺铂和5-氟尿嘧啶诱导化疗后序贯放化疗或单纯放化疗用于Ⅲ-Ⅳ期不可切除头颈部癌：一项随机Ⅱ期研究的结果

Strahlenther Onkol. 2015 Aug;191(8):635-41. doi: 10.1007/s00066-015-0829-z. Epub 2015 Mar 18.

Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck.培美曲塞联合顺铂和西妥昔单抗治疗复发性或转移性头颈部鳞状细胞癌的 II 期研究。

Eur J Cancer. 2013 Sep;49(13):2877-83. doi: 10.1016/j.ejca.2013.05.002. Epub 2013 May 30.

Neoadjuvant TPF in locally advanced head and neck cancer can be followed by radiotherapy combined with cisplatin or cetuximab: a study of 157 patients.局部晚期头颈部肿瘤新辅助 TPF 化疗后可采用顺铂或西妥昔单抗联合放疗：157 例患者研究。

Anticancer Drugs. 2013 Jul;24(6):623-9. doi: 10.1097/CAD.0b013e328360b9d6.

Chemo re-irradiation in recurrent head and neck cancer: a single institution experience.复发性头颈癌的化疗再照射：单机构经验

J BUON. 2012 Apr-Jun;17(2):397.

[Oncologic topics].

Arch Otorhinolaryngol Suppl. 1985;2:172-84.

本文引用的文献

Erratum to: Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck.《头颈部复发性鳞状细胞癌再次接受西妥昔单抗或顺铂化疗的再照射》勘误

Strahlenther Onkol. 2015 Sep;191(9):763-4. doi: 10.1007/s00066-015-0882-7.

External validation of a prognostic model estimating the survival of patients with recurrent high-grade gliomas after reirradiation.预测复发性高级别胶质瘤患者再程放疗后生存情况的预后模型的外部验证

Pract Radiat Oncol. 2015 May-Jun;5(3):e143-e150. doi: 10.1016/j.prro.2014.10.001. Epub 2014 Nov 18.

External validation of a Cox prognostic model: principles and methods.Cox 预后模型的外部验证：原则与方法。

BMC Med Res Methodol. 2013 Mar 6;13:33. doi: 10.1186/1471-2288-13-33.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验